Agnieszka K. Ć.
- Country
- Poland
- Department
- NA
Research Overview
- Efficacy and Safety Evaluation of Paltusotine in Adults with Carcinoid Syndrome Secondary to Well-Differentiated Neuroendocrine Tumors: A Randomized, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of [177Lu]Lu-DOTA-TATE and Octreotide LAR in Grade 1 and 2 Advanced Gastroenteropancreatic Neuroendocrine Tumors
- A Phase 2/3, multicenter, randomized open-label study of zanzalintinib vs everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors
Data & Insights
Has run more than one trial at 35 of 95 partner sites.
Specializations
Breast oncology
Clinical research in breast cancer spans hormone receptor-positive and HER2-negative disease, triple-negative breast cancer, HER2-positive subtypes, and early breast cancer with recurrence risk.
- Metastatic breast cancer
- Endocrine-resistant disease
- Adjuvant and neoadjuvant treatment
The therapeutic profile includes targeted and immunologic strategies for advanced disease and postoperative recurrence prevention.
Thoracic malignancies
Research activity is strongly centered on non-small cell lung cancer and small cell lung cancer, including locally advanced, metastatic, and resectable settings.
- EGFR-mutated lung cancer
- PD-L1-positive disease
- Extensive-stage small cell lung cancer
Additional involvement includes mesothelioma and biomarker-defined thoracic tumors with actionable genomic alterations.
Gastrointestinal and hepatobiliary oncology
The investigator is involved in studies of colorectal cancer, gastric cancer, gastroesophageal junction adenocarcinoma, pancreatic cancer, and biliary tract cancer.
- Gastrointestinal stromal tumor
- Hepatocellular carcinoma
- Neuroendocrine tumors
Therapeutic interests also extend to solid tumors with MSI-H, dMMR, or other molecular features guiding treatment selection.
Genitourinary and gynecologic cancers
Clinical trial involvement covers ovarian cancer, endometrial cancer, cervical cancer, urothelial carcinoma, and prostate cancer, across both advanced and recurrent disease settings.
- Renal cell carcinoma
- Bladder cancer
- Metastatic castration-resistant prostate cancer
The therapeutic focus includes targeted approaches and immunotherapy for biomarker-selected tumors.
Hematologic malignancies and immunotherapy
Research spans lymphoma, multiple myeloma, acute myeloid leukemia, and other hematologic malignancies, with parallel interest in immune-based cancer therapy.
- Diffuse large B-cell lymphoma
- Classical Hodgkin lymphoma
- Chronic lymphocytic leukemia
Additional activity includes melanoma and other advanced solid tumors treated with checkpoint inhibitor and targeted therapy strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.